Analyst consensus rating
Roivant Sciences Analyst Rating: Strong Buy
Direct answer
Roivant Sciences's consensus rating is Strong Buy.
11 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $48.27.
Forecast evidence checked October 19, 2026.
Get free Roivant Sciences email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $33.53
- Average price target
- $48.27
- High price target
- $55.00
- Low price target
- $41.00
- Low target gap
- +22.3%
- Target upside
- +44%
- High target gap
- +64%
- Target range width
- 41.8%
- Consensus rating
- Strong Buy
- Analysts
- 11
- Evidence date
- October 19, 2026
- Valid through
- October 26, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Roivant Sciences?
Roivant Sciences has a verified Strong Buy consensus. The same dataset has an average price target of $48.27.
How far are Roivant Sciences's low and high targets from the recorded price?
The low target implies +22.3%, while the high target implies +64%.
How many analysts are included in Roivant Sciences's consensus?
The verified consensus includes 11 analysts.
How is Roivant Sciences's target upside or downside calculated?
The average target of $48.27 is divided by the recorded price of $33.53, then one is subtracted to produce +44%. This does not guarantee a future return.
When was Roivant Sciences's analyst forecast verified?
The data was verified on 2026-10-19. The dataset is valid through 2026-10-26.